ARCHIVES

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

This article is from The Cancer Letter archive.

Vol. 37 No. 40 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

In Brief: AACR, ASCO to Sponsor Joint Symposium on Oncogenes; AACI Hosts Congressional Staff

February 15, 1985

Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio

July 4, 1997

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

Also in this 8-page issue: Bush nominates McClellan to head CMS.

February 27, 2004